Here's some of HealthDay's top stories for Friday, July 23:
Vaccinations on the rise in states hit hard by Delta variant. After weeks of stagnant vaccination rates, states with high levels of vaccine resistance are seeing an uptick in new immunizations as the COVID Delta variant spreads quickly, filling up hospitals. Read more
Arguing for & against approval of controversial Alzheimer's drug. The FDA earlier this month gave its OK to the first new Alzheimer's drug in years -- despite its own panel voting 10-1 against approval. Now, some doctors and hospitals are refusing to use the expensive drug, called Aduhelm. Who's right? Read more
Money may buy you a longer life. A new study of 5,400 Americans finds that people with healthier bank accounts in middle age tended to live longer. A similar effect was found among twins, suggesting that more than just genetics is at play. Read more
Are antibiotics the only answer for UTIs? Millions of women are stricken with a urinary tract infection each year, and the typical response from their doctors is a prescription for antibiotics. But is that really solving the problem?Read more
A new drug offers hope against psychosis. Hallucinations, delusions, agitation: Hallmarks of psychotic episodes, which can incapacitate the frail or ill and create a huge burden for caregivers. Now, research suggests that a drug that's been effective against Parkinson's psychosis may work for other forms of the condition. Read more
